GT Biopharma Inc logo

GT Biopharma Inc

LTS:0RU9 (USA)  
€ 1147194.00 (0%) Nov 27
At Loss
P/B:
3.05
Market Cap:
€ 6.09M ($ 6.42M)
Enterprise V:
€ -3.23M ($ -3.40M)
Volume:
-
Avg Vol (2M):
-
Trade In:

GT Biopharma Inc Valuation Measures